Shopping Cart
- Remove All
- Your shopping cart is currently empty
TL4-12 is a specific MAP4K2/GCK inhibitor that inhibits IKZF1 and BCL-6.TL4-12 inhibits MM cell proliferation and induces apoptosis, and can be used in the study of multiple myeloma (MM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 100 € | In Stock | |
5 mg | 202 € | In Stock | |
10 mg | 305 € | In Stock | |
25 mg | 511 € | In Stock | |
50 mg | 729 € | In Stock | |
100 mg | 997 € | In Stock | |
500 mg | 1.976 € | In Stock |
Description | TL4-12 is a specific MAP4K2/GCK inhibitor that inhibits IKZF1 and BCL-6.TL4-12 inhibits MM cell proliferation and induces apoptosis, and can be used in the study of multiple myeloma (MM). |
In vitro | The GCK inhibitor TL4-12 downregulates IKZF1 and BCL-6 in a dose-dependent manner, resulting in proliferation inhibition and induction of apoptosis in multiple myeloma cells[1]. |
Alias | TL412, TL4 12 |
Molecular Weight | 500.52 |
Formula | C25H27F3N6O2 |
Cas No. | 1620820-12-3 |
Smiles | O=C(NC=1C=C(C=C(C1)C(F)(F)F)N2CCN(C)CC2)C3=CC=C(C(OC4=NC=NC(=C4)NC)=C3)C |
Relative Density. | 1.324 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
Solubility Information | DMSO: 5 mg/mL (2.00 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.